PMID: 9444988Jan 28, 1998Paper

In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16

Journal of Virology
W I WhiteJ A Suzich

Abstract

Human papillomavirus type 16 (HPV-16) is strongly associated with the development of cervical cancer. Studies of model systems with animal papillomaviruses have demonstrated the importance of neutralizing antibodies in preventing papillomavirus-associated disease. The assessment of neutralizing antibody responses against HPV-16, previously hampered by the lack of a viral source, was enabled by the recent propagation of an HPV-16 stock in xenografted severe combined immunodeficiency (SCID) mice. HPV-16 infection of an immortalized human keratinocyte cell line was demonstrated by detection of an HPV-16-specific spliced mRNA amplified by reverse transcriptase PCR. Infection was blocked by preincubation of the virus with antiserum generated against HPV-16 virus-like particles (VLPs) composed of the major capsid protein, L1. To examine potential cross-neutralizing activity among the different genital HPV types, rabbit antisera to L1 VLPs corresponding to HPV-6, -11, -18, -31, -33, -35, -39, and -45 were assayed for the ability to block the HPV-16 infection of cultured cells. Antiserum raised against HPV-33 L1 VLPs was the only heterologous antiserum which inhibited HPV-16 infection. Thus, a neutralization assay for HPV-16 may help t...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R KirnbauerJ T Schiller
Jul 1, 1990·Journal of Virology·N D Christensen, J W Kreider
Sep 9, 1991·International Journal of Cancer. Journal International Du Cancer·S GhimA B Jenson
Nov 1, 1990·Journal of Virology·N D ChristensenP A Welsh
Mar 1, 1988·The Journal of Cell Biology·P BoukampN E Fusenig
Mar 1, 1989·Journal of Virology·A TanakaY Ito
Aug 1, 1985·Virology·K SeedorfW G Röwekamp
Feb 1, 1987·Journal of Virology·J W KreiderJ A Weber
Aug 1, 1987·Journal of Virology·L T ChowT R Broker
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Sep 1, 1995·Annals of Internal Medicine·W C Phelps, K A Alexander
Sep 1, 1995·The Journal of Investigative Dermatology·L H SmithJ W Kreider
Nov 1, 1994·The Journal of Infectious Diseases·M M ManosC M Wheeler
Feb 1, 1994·The Journal of Infectious Diseases·A HildesheimM E Sherman
Sep 1, 1993·The Journal of Investigative Dermatology·L H SmithR Isseroff
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel

❮ Previous
Next ❯

Citations

Jul 30, 2003·Journal of Virology·Heribert WarzechaRobert C Rose
Jun 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dohun PyeonPaul Ahlquist
Dec 20, 2007·The Journal of General Virology·Raeda Z RizkMichael Pawlita
Aug 28, 2014·Frontiers in Oncology·Nathalie Dauphin McKenzieTulay Koru-Sengul
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T. S. Onon, H. C. Kitchener
May 20, 2006·Reviews in Medical Virology·Margaret A Stanley
Jan 22, 2011·Expert Opinion on Therapeutic Patents·Hee-Jeong ChoYoung Bong Kim
Feb 7, 2001·Journal of the National Cancer Institute. Monographs·J T Schiller, D R Lowy
Oct 16, 2003·The Nurse Practitioner·Alana Heise
May 8, 2009·Immunology and Cell Biology·Balasubramanyam KaranamRichard B S Roden
Oct 17, 2001·The Journal of General Virology·Katharina SlupetzkyReinhard Kirnbauer
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E ScheurerK Adler-Storthz
Feb 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·John H LeeMichelle A Ozbun
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Antonella AgodiSalvatore Travali
Jun 1, 2010·Journal of Medical Virology·Gilbert CornutUNKNOWN Canadian Women's HIV Study Group
Dec 18, 2008·The Journal of General Virology·Alessandra HandisuryaReinhard Kirnbauer
Feb 13, 2001·Journal of Cellular Physiology·D M Da SilvaW M Kast
Jan 25, 2000·The Journal of General Virology·G SibbetM S Campo
Jun 18, 2009·Protein Science : a Publication of the Protein Society·Maxime J J FleuryPierre Coursaget
Sep 23, 2006·Nature Reviews. Cancer·Richard Roden, T-C Wu
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Alba-Lucia CombitaPierre Coursaget
Mar 14, 2000·Seminars in Cancer Biology·F Breitburd, P Coursaget

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.